The authors found that the neutralizing antibody-mediated abrogation of HMGB1 attenuated silica-induced lung inflammation, fibrosis, and EMT, whereas the application of recombinant HMGB1 exerted the opposite effect (Ma et al., 2020). The gene discussed is HMGB1; the disease is inflammatory response.